Sichuan Biokin Pharmaceutical Co., Ltd. engages in the design, development, and manufacturing of small-molecule synthetic drugs, and large-molecule biomedicine. The company was founded by YI Zhu on August 17, 2006 and is headquartered in Chengdu, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company